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INTRODUCTION
induced chronic morbidities such as acute and late bowel toxicity, bladder ulcers, telengiectasia and contracted bladder and bone necrosis. These toxicities are dose-related and different structures have varying tolerance to radiation. The availability of data on tissue tolerances makes it imperative to respect the tolerance of critical structures such as the kidneys, liver, spinal cord, small bowel, rectum etc. and reduce associated morbidities while maintaining a good quality of life.
In most clinical situations, the radiation oncologist is compromised in prescription to treat to tolerance doses of normal tissues rather than to specific tumoricidal dose due to the vicinity of normal structures to the tumor. Intensity modulated radiotherapy (IMRT) has the potential to increase dose to the target. A number of studies have demonstrated the superiority of the physical dose distribution of IMRT compared to other modalities with application in brain tumors, head and neck cancers and prostate cancer treatments. [3, 14, 16, 21] As compared to conventional beams, the complexity of IMRT dose patterns makes the verification of the match between planned and delivered doses considerably more difficult. The accuracy of delivered doses is a critical issue for ongoing quality assurance in an IMRT program. Several different techniques have been described and used for clinical implementation of IMRT. These include the "step and shoot" auto sequence multileaf collimator (MLC), dynamic MLC and the physical intensity modulation. The "step and shoot" auto sequence MLC technique delivers an intensity modulated photon field by irradiating a sequence of static MLC ports. The dynamic MLC technique delivers an intensity modulated photon field by moving the collimator leaves during irradiation. [8] Physical intensity modulators are being used to deliver IMRT since the advent of inverse planning software.
[13] Schulz [18] and Chang et al, [4] have shown in a comparative study between different techniques of IMRT, that the MLC technology requires considerably longer time (100-400%) to deliver the treatment fiducial markers to lasers. The CT images were then transferred to the treatment-planning computer through direct cable network.
Contouring of the tumor and critical normal structures was done by the radiation oncologist with the assistance of a radiologist on every CT slice. Gross tumor volume (GTV) is taken as the gross extent of the tumor as shown by imaging studies as compared to PIM-based IMRT. They also found a better target coupled with the findings on physical examination in lymphoma volume dose uniformity with PIMs. Sherouse has elaborated cases and clinical target volume (CTV) was defined at 10 mm that the solid filters are the gold standard and MLC can be an from the GTV. In postoperative cases, the CTV for every case acceptable compromise.
[20] He has described solid milled physical was individualized according to the drainage areas, information modulators as the technology of choice for implementing fluence regarding the tumor bed as per surgical notes and knowledge modulation for IMRT. PIMs are more reliable as the photons regarding organ motion. The uniformity of margin was not are absorbed the same way every time by the PIM, whereas kept if some highly sensitive structure was in the proximity the initial validation measurement in MLC may vary a week PTV was placed at 3-5 mm outside the CTV and the beam edge later.
[20] Hence a day-to-day quality assurance is required to to PTV was placed at 3-4 mm by the medical physicist. maintain an MLC-based IMRT programme. The resolution of Prescription of dose to the target and defining dose constraints PIM is greater in one of the two dimensions because of the size for the critical normal structure such as the liver, cord, kidneys, of the MLC leaves, which is typically either 1 cm or 5 mm and bowel etc. was done keeping in mind the partial tolerances the problem of time invariance arises with moving tissues. In from the published literature [5] [ Table 2 ]. This patient data dynamic MLC, if the target moves left while the right segment facilitated virtual reconstruction of patient anatomy with tumor is being treated and weaves right while the left segment is and organs at risk. treated, there is a potential of 100% error.
[20]
A photon fluence pattern of each individual beam was We present our initial experience with the designing, generated that met the defined dose constraints on the threeimplementation and dosimetric aspects of IMRT plans of 11 dimensional treatment planning system (3-D TPS -Plato, patients.
Nucletron International) with inverse planning and optimization software. The fluence patterns were used to design and cut MATERIALS AND METHODS special Necupur templates on computerized numerically controlled 3-D milling machine (Autimo system, Hek Patients of abdominal malignancies form the study group. It is Medizintechnik). These templates were subsequently used to a heterogeneous population with postchemotherapy mould physical intensity modulators (PIMs) of cerro bend.
[13]
nonHodgkin's lymphoma, postoperative cases of periampullary carcinoma, carcinoma stomach, caecum, colon, gall bladder and Resimulation was done for verification of isocenter and each renal cell carcinoma referred for radiotherapy [ Table 1 ].
angle of beam entry as per optimized plan with the help of previously placed fiducial markers under the supervision of .
Planning-A thermoplastic cast was made in the treatment position on the simulator using laser beam alignment and fiducial markers were placed on the thermoplastic cast. A planning computed tomography (CT) scan with contrast at cross sections of 3 mm was performed after aligning the external Percentage PTV receiving 100% of prescribed dose (V100), percentage PTV receiving less than 93% dose (V93) and percentage PTV receiving more than 110% of prescribed dose (V110) were evaluated as per Collaborative Working Group (CWG) recommendations. [3] The homogeneity index (H.I.) was calculated by evaluating the percentage variation between 95% and 10% volume of the PTV using the following formula H.I. = D 10 /D 95 where D 10 is the dose received by 10% PTV and D 95 is the dose received by 95% of the PTV. [9, 11] Statistical analysis was done using SPSS software version 10. Disease-free survival (DFS) and overall survival (OS) were calculated by Kaplan Meier method. The DFS was calculated from the date of completion of the planned treatment and OS was calculated from the date of commencement of treatment. For calculating DFS, "disease recurrence", "residual disease" the bowel, with respect to the GTV [ Table 4 ].
The full right kidney dose was 22. There is paucity of data regarding the practice of IMRT in abdominal malignancies in literature using physical intensity The median age was 51 (31-74) years. The median follow-up modulators. We have presented the initial observations and was 15 months. Eight out of 11 patients achieved a complete results using PIMs; and this is the only study highlighting daily response (C.R.), one had partial response (P.R.), one had reproducibility, accuracy and outcomes using this technique so progressive disease and both these patients were lost to followfar available in literature [ Table 5 ]. up. One patient had a relapse and is undergoing salvage chemotherapy. Both incomplete responses were at the local The only technical advantage of MLC in present time seems to site. The average number of IMRT fields was six (range 5-11).
be that it does not involve manufacturing of a physical modulator For PTV, V100 was 90.3% (70-98%), V93 was 2.4% (0-5%) and which is time-consuming and that the technologist does not V110 was 10% (2-23%). For GTV, V100 was 90.3% (70-98%), V93 have to go in the treatment room again and again to change was 2.3% (0-4%) and V110 was 11.2% (2-30%). The homogeneity the PIM. index (H.I.) calculated by evaluating the percentage variation between 95% and 10% volume of the PTV was 1.1 (1.1-1.3) and
The TD 5/5 of 23 Gy for whole organ irradiation of kidneys, 30 95% and 10%volume of the GTV was 1.1 [ . [7] kidney received less than 21.9 Gy and 1/3 rd organ received less than 25.25 Gy. With IMRT plans we were able to achieve an average reduction in mean doses by 50% to the entire liver, 51% to 2/3 rd and 42% The TD 5/5 of 30 Gy for whole liver, 35 Gy for 2/3 rd liver and 50 to 1/3 rd liver; 57% to the entire right kidney, 59% to 2/3 rd and Gy for 1/3 rd liver has been accepted, the end point being 54% to 1/3 rd right kidney; 56% to entire left kidney, 58% to 2/3 rd hepatitis or liver failure. [5] In our series, the entire liver received events.
RESULTS
of the and 50% to 1/3 rd of the left kidney; 66% to the cord and 27% to a dose of 25 Gy (12 Gy -41 Gy), 2/3 rd received a dose of 24.2 Gy 55  51  38  38  37  33  33  38  36  32  36  41  32  45  41  42  23  22  24  22  20  22  26  20  31  16  15  16  5 1  4 9  ---2 4  2 3  2 4  3 0  2 5  3 3  3 1  2 9  3 6  47  45  23  22  33  27  21  40  30  21  33  --40  40  21  22  24  21  21  22  20  26  30  20  21  21  39  18  17  18  25  30  46  28  22  33  19  19  20  22  18  55  18  18  20  18  18  20  30  31  42  ---22  21  22  -49  10  12  22  10  11  15  31  31  55  23  22  27  17  15  18  19  16 GTV* -Gross tumor volume, PTV † -Planning target volume. [12] have reported on treatment of 10 cases of higher rates of tumor control. pancreatic cancer with IMRT and described 1/3 rd of small bowel receiving 30.2±12.9Gy. The median volume of small bowel In our series, it was possible to achieve an average reduction in receiving 50 Gy was 19.2±11.2%. The median volume of small the mean dose by 50 % to the liver, 57 % to the right kidney, bowel that received greater than 60 Gy was 12.5±4.8%. Using 56% to left kidney, 66 % to the cord and 27 % to the bowel, with 30  19  16  19  --22  21  18  19  35  38  34  44  21  20   39  12  29  35  59  31  31  28  44   40  47  15  30  4  11  20  13  10  31  13 45 Gy).
Lyman Kutcher model, they predicted small bowel complication probability of 9.3±6% with IMRT.
Portelance et al, in a dosimetric analysis have shown the small bowel to receive 11.01±5.67% of prescribed dose by 4-field IMRT plan. Similarly the doses to the rectum and bladder have also been reduced drastically. [15] In our series, we were able to limit the dose to 24 Gy (19 Gy-36 Gy) to the entire bowel, 25 Gy (18 Gy-32 Gy) to 2/3 rd bowel and 32 Gy (22 Gy-39 Gy) to 1/3 rd bowel.
However, there are some areas of concern in planning and delivery of IMRT. Although parameters such as organ movements and daily patient set-up variation are accounted for to some extent in the concept of PTV, there is no provision for the shrinkage of the gross tumor and subsequent change in geometry over the course of radiotherapy.
In view of the fact that IMRT introduces steep gradients near respect to the GTV.
IMRT will open up new vistas in cases of reirradiation wherein critical structures have already received near tolerance doses of radiation. ) .
